Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Non-Current Assets (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Other Non-Current Assets for 7 consecutive years, with $1.3 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Other Non-Current Assets rose 2249.12% year-over-year to $1.3 million, compared with a TTM value of $1.3 million through Sep 2019, up 2249.12%, and an annual FY2018 reading of $57000.0, changed 0.0% over the prior year.
  • Other Non-Current Assets was $1.3 million for Q3 2019 at Larimar Therapeutics, roughly flat from $1.3 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.3 million in Q2 2019 and bottomed at $57000.0 in Q3 2017.
  • Average Other Non-Current Assets over 5 years is $223000.0, with a median of $84000.0 recorded in 2015.
  • The sharpest move saw Other Non-Current Assets plummeted 61.16% in 2015, then skyrocketed 2249.12% in 2019.
  • Year by year, Other Non-Current Assets stood at $94000.0 in 2015, then crashed by 35.11% to $61000.0 in 2016, then fell by 6.56% to $57000.0 in 2017, then changed by 0.0% to $57000.0 in 2018, then surged by 2249.12% to $1.3 million in 2019.
  • Business Quant data shows Other Non-Current Assets for LRMR at $1.3 million in Q3 2019, $1.3 million in Q2 2019, and $57000.0 in Q1 2019.